Combined Therapy Against Recurrent Hemangiopericytoma: A Case Report.

Xiao-Dong Li,Jing-Ting Jiang,Chang-Ping Wu
DOI: https://doi.org/10.3969/j.issn.2095-3941.2012.02.012
2012-01-01
Abstract:Department of Oncology, The Third Affiliated Hospital of Soochow University, Changzhou 213003, China A patient with a seven-year history of recurrent metastatic hemangiopericytoma (HPC) was admitted. During his treatment, he received surgical resection, radiotherapy, radiofrequency hyperthermia and chemotherapy using combined doxorubicin, dacarbazin, vincristine, ginsenoside Rg3, and recombinant human endostatin. This synergistic method provides an encouraging model for treating HPC.
What problem does this paper attempt to address?